Orforglipron for Weight Loss in Teens
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a once-daily pill (orforglipron) to help adolescents with obesity or overweight plus related health problems lose weight. It offers a new option for teens who have struggled to lose weight with diet and exercise alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old (adolescent).
- You have obesity (BMI at or above 95th percentile for your age and sex) OR are overweight (BMI 85th to 94th percentile) with a related health problem like high blood pressure, type 2 diabetes, or sleep apnea.
- You have already tried to lose weight with diet and exercise for at least 3 months without lasting success.
- You have not lost more than 11 pounds in the past 3 months without trying.
- You have not had weight-loss surgery and are not planning to have any.
- You do not have type 1 diabetes or a medical condition that directly causes obesity (like a hormone problem).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication for children and teens with obesity or overweight who have not been able to lose enough weight with diet and exercise alone. It aims to see if a new treatment can help them safely lose weight and improve related health problems.
This trial tests an investigational oral medication to help Chinese adults with overweight or obesity, plus related health issues, lose weight. It focuses on improving weight loss and overall health in this group.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests an investigational pill called aleniglipron to see if it helps people with obesity or overweight who also have a weight-related health problem (like high blood pressure) lose weight safely. It is a Phase 3 trial, meaning it is in the final stages before seeking approval.
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.